NIIMBL announces 32 projects funded through the American Rescue Plan

By The Science Advisory Board staff writers

December 22, 2021 -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced 32 coronavirus response projects to multiple organizations across the U.S. that will receive funding through the American Rescue Plan.

The selected projects are designed to help the U.S. prevent, prepare for, and respond to coronavirus public health threats. NIIMBL selected projects that it said provide test beds for process development; support vaccine production, including the quality and distribution of vaccines; and that help train a diverse biopharmaceutical manufacturing workforce.

A summary of the projects can be found at NIIMBL.org.

NIST gives $135M to NIIMBL to bolster U.S. supply chains
The U.S. National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced it has received $153 million in new funding from...
NIIMBL spends $4.6M to fund biopharmaceutical projects
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is spending $4.6 million to fund 10 new biopharmaceutical manufacturing...
Gene Schaefer joins NIIMBL as senior fellow
Gene Schaefer, ScD, has joined the U.S. National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) as senior fellow, effective April...
NIIMBL funds new biopharmaceutical manufacturing projects
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced that it is funding 14 new projects in technology, workforce...

Copyright © 2021 scienceboard.net


Conferences
HPLC 2022
June 18-23
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter